TipRanks
Zevra Therapeutics (DE:1GDA)
FRANKFURT:1GDA

Compare Zevra Therapeutics (1GDA) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Zevra Therapeutics
€9.84
€599.88M
10.82
7.89%
9 Buy
0 Hold
0 Sell
Strong Buy
Vanda
$5.44
$274.50M
-0.93
-17.78%
4 Buy
0 Hold
0 Sell
Strong Buy
Ovid Therapeutics
$2.88
$470.67M
-4.56
38.61%
9 Buy
0 Hold
0 Sell
Strong Buy
Design Therapeutics
$15.59
$682.77M
-8.29
50.69%
4 Buy
0 Hold
0 Sell
Strong Buy
Pharming Group
$11.77
$694.00M
64.40
-35.39%
2 Buy
0 Hold
0 Sell
Moderate Buy
Apnimed, Inc.
$26.25
$775.58M
―
-28.68%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:1GDA
Zevra Therapeutics
9.98
0.88
9.67%
VNDA
Vanda
4.30
-0.93
-17.78%
OVID
Ovid Therapeutics
2.19
0.44
25.14%
DSGN
Design Therapeutics
9.78
3.16
47.73%
PHAR
Pharming Group
9.44
-5.11
-35.12%
APMD
Apnimed, Inc.
17.83
-7.17
-28.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts